$RPRX News

Royalty Pharma plc (RPRX) Presents at RBC Capital Markets Global Healthcare Conference 2026 Transcript

Royalty Pharma: Strong Execution, Expanding Pipeline And More Firepower Ahead

Royalty Pharma plc (RPRX) Presents at Bank of America Global Healthcare Conference 2026 Transcript

Income Investors Should Know That Royalty Pharma plc (NASDAQ:RPRX) Goes Ex-Dividend Soon

10% Of This Royalty Pharma Insider's Holdings Were Sold

Royalty Pharma to present at upcoming investor conferences

Citigroup Maintains Buy on Royalty Pharma, Raises Price Target to $66

JP Morgan Maintains Overweight on Royalty Pharma, Raises Price Target to $58

Royalty Pharma Q1 Earnings Call Highlights

Royalty Pharma plc Q1 2026 Earnings Call Summary

Royalty Pharma PLC (RPRX) Hit a 52 Week High, Can the Run Continue?

Royalty Pharma (NASDAQ:RPRX) Beats Q1 Estimates and Raises Guidance, Fueling Strong Momentum

Royalty Pharma plc (RPRX) Q1 2026 Earnings Call Transcript

Royalty Pharma Reports Q1 2026 Results: Full Earnings Call Transcript

Royalty Pharma plc 2026 Q1 - Results - Earnings Call Presentation

Royalty Pharma Q1 Adj. EPS $1.30 Beats $1.21 Estimate, Sales $631.000M Miss $1.235B Estimate

These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar

Codexis (CDXS) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release

Royalty Pharma (RPRX) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

A Look At Royalty Pharma (RPRX) Valuation After Its Recent Share Price Momentum